S&P 500   3,743.68 (-1.25%)
DOW   30,027.28 (-0.95%)
QQQ   277.70 (-1.57%)
AAPL   144.43 (-1.14%)
MSFT   245.92 (-1.19%)
META   135.75 (-3.23%)
GOOGL   99.55 (-2.06%)
AMZN   119.13 (-1.62%)
TSLA   234.66 (-5.93%)
NVDA   128.66 (-2.29%)
NIO   15.82 (-5.44%)
BABA   83.84 (-0.32%)
AMD   66.24 (-2.44%)
T   15.87 (-1.37%)
MU   53.79 (-0.32%)
CGC   2.99 (-4.78%)
F   12.32 (-0.32%)
GE   66.94 (-0.89%)
DIS   99.40 (-2.01%)
AMC   7.17 (-8.43%)
PYPL   91.57 (-1.31%)
PFE   43.84 (-1.39%)
NFLX   229.85 (-4.52%)
S&P 500   3,743.68 (-1.25%)
DOW   30,027.28 (-0.95%)
QQQ   277.70 (-1.57%)
AAPL   144.43 (-1.14%)
MSFT   245.92 (-1.19%)
META   135.75 (-3.23%)
GOOGL   99.55 (-2.06%)
AMZN   119.13 (-1.62%)
TSLA   234.66 (-5.93%)
NVDA   128.66 (-2.29%)
NIO   15.82 (-5.44%)
BABA   83.84 (-0.32%)
AMD   66.24 (-2.44%)
T   15.87 (-1.37%)
MU   53.79 (-0.32%)
CGC   2.99 (-4.78%)
F   12.32 (-0.32%)
GE   66.94 (-0.89%)
DIS   99.40 (-2.01%)
AMC   7.17 (-8.43%)
PYPL   91.57 (-1.31%)
PFE   43.84 (-1.39%)
NFLX   229.85 (-4.52%)
S&P 500   3,743.68 (-1.25%)
DOW   30,027.28 (-0.95%)
QQQ   277.70 (-1.57%)
AAPL   144.43 (-1.14%)
MSFT   245.92 (-1.19%)
META   135.75 (-3.23%)
GOOGL   99.55 (-2.06%)
AMZN   119.13 (-1.62%)
TSLA   234.66 (-5.93%)
NVDA   128.66 (-2.29%)
NIO   15.82 (-5.44%)
BABA   83.84 (-0.32%)
AMD   66.24 (-2.44%)
T   15.87 (-1.37%)
MU   53.79 (-0.32%)
CGC   2.99 (-4.78%)
F   12.32 (-0.32%)
GE   66.94 (-0.89%)
DIS   99.40 (-2.01%)
AMC   7.17 (-8.43%)
PYPL   91.57 (-1.31%)
PFE   43.84 (-1.39%)
NFLX   229.85 (-4.52%)
S&P 500   3,743.68 (-1.25%)
DOW   30,027.28 (-0.95%)
QQQ   277.70 (-1.57%)
AAPL   144.43 (-1.14%)
MSFT   245.92 (-1.19%)
META   135.75 (-3.23%)
GOOGL   99.55 (-2.06%)
AMZN   119.13 (-1.62%)
TSLA   234.66 (-5.93%)
NVDA   128.66 (-2.29%)
NIO   15.82 (-5.44%)
BABA   83.84 (-0.32%)
AMD   66.24 (-2.44%)
T   15.87 (-1.37%)
MU   53.79 (-0.32%)
CGC   2.99 (-4.78%)
F   12.32 (-0.32%)
GE   66.94 (-0.89%)
DIS   99.40 (-2.01%)
AMC   7.17 (-8.43%)
PYPL   91.57 (-1.31%)
PFE   43.84 (-1.39%)
NFLX   229.85 (-4.52%)
NASDAQ:WBA

Walgreens Boots Alliance - WBA Stock Forecast, Price & News

$32.90
-0.49 (-1.47%)
(As of 10/5/2022 11:40 AM ET)
Add
Compare
Today's Range
$32.71
$33.27
50-Day Range
$31.40
$42.04
52-Week Range
$31.23
$55.00
Volume
84,573 shs
Average Volume
7.49 million shs
Market Capitalization
$28.43 billion
P/E Ratio
5.31
Dividend Yield
5.92%
Price Target
$44.69

Walgreens Boots Alliance MarketRank™ Forecast

Analyst Rating
Hold
1.90 Rating Score
Upside/​Downside
36.0% Upside
$44.69 Price Target
Short Interest
Healthy
3.16% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.38
Upright™ Environmental Score
News Sentiment
0.62mentions of Walgreens Boots Alliance in the last 14 days
Based on 17 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-8.37%
From $5.02 to $4.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.88 out of 5 stars

Retail/Wholesale Sector

37th out of 216 stocks

Drug Stores & Proprietary Stores Industry

1st out of 6 stocks

WBA stock logo

About Walgreens Boots Alliance (NASDAQ:WBA) Stock

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

WBA Stock News Headlines

Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear (WBA)
Will Rite Aid stock ever recover? Unless Rite Aid can improve its revenue, the best advice for investors may involve staying away from the stock.
3 Dow Stocks That Are Screaming Buys in October
Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $32.00
Walgreens Boots Alliance (NASDAQ:WBA) Price Target Cut to $32.00
Walgreens Joins Sustainable Medicines Partnership
WBA Walgreens Boots Alliance, Inc.
This 5.8% Hyper-Yield Dividend Stock Is Great for Retirees
Walgreens Boots Alliance (NASDAQ: WBA)
Walgreens Boots' (WBA) Product Expansion Aids Amid Rivalry
Expert Ratings for Walgreens Boots Alliance
Walgreens realigns leadership team after $1.3B acquisition
Walgreens Boots To Buy Out Shields Health For Around $1.37 Bln; Stock Down
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

WBA Company Calendar

Last Earnings
1/06/2022
Ex-Dividend for 9/9 Dividend
8/18/2022
Dividend Payable
9/09/2022
Today
10/05/2022
Next Earnings (Confirmed)
10/13/2022
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
315,000
Year Founded
2014

Price Target and Rating

Average Stock Price Forecast
$44.69
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+35.8%
Consensus Rating
Hold
Rating Score (0-4)
1.90
Research Coverage
10 Analysts

Profitability

Net Income
$2.54 billion
Pretax Margin
4.20%

Debt

Sales & Book Value

Annual Sales
$132.51 billion
Cash Flow
$7.70 per share
Book Value
$27.54 per share

Miscellaneous

Free Float
713,876,000
Market Cap
$28.43 billion
Optionable
Optionable
Beta
0.65

Social Links


Key Executives

  • Mr. Stefano Pessina (Age 81)
    Exec. Chairman
    Comp: $131.06k
  • Ms. Rosalind Gates Brewer (Age 60)
    CEO & Director
    Comp: $8.13M
  • Mr. James Kehoe (Age 60)
    Exec. VP & Global CFO
    Comp: $2.9M
  • Ms. Ornella  BarraMs. Ornella Barra (Age 69)
    Chief Operating Officer of International
    Comp: $3.74M
  • Mr. John T. Standley (Age 59)
    Exec. VP & Pres of Walgreens
    Comp: $2.31M
  • Mr. Manmohan Mahajan (Age 42)
    Sr. VP, Global Controller & Chief Accounting Officer
  • Mr. Francesco Tinto
    Global Chief Information Officer & Sr. VP
  • Mr. Gerald Gradwell (Age 54)
    Sr. VP of Investor Relations
  • Ms. Danielle Carim Gray (Age 43)
    Exec. VP & Global Chief Legal Officer
  • Mr. Aaron C. Radelet
    Global Chief Communications Officer & Sr. VP













WBA Stock - Frequently Asked Questions

Should I buy or sell Walgreens Boots Alliance stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last twelve months. There are currently 1 sell rating and 9 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View WBA analyst ratings
or view top-rated stocks.

What is Walgreens Boots Alliance's stock price forecast for 2022?

10 brokerages have issued 12 month target prices for Walgreens Boots Alliance's shares. Their WBA share price forecasts range from $32.00 to $56.00. On average, they anticipate the company's stock price to reach $44.69 in the next year. This suggests a possible upside of 36.0% from the stock's current price.
View analysts price targets for WBA
or view top-rated stocks among Wall Street analysts.

How have WBA shares performed in 2022?

Walgreens Boots Alliance's stock was trading at $52.16 at the beginning of 2022. Since then, WBA shares have decreased by 37.0% and is now trading at $32.85.
View the best growth stocks for 2022 here
.

When is Walgreens Boots Alliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 13th 2022.
View our WBA earnings forecast
.

How can I listen to Walgreens Boots Alliance's earnings call?

Walgreens Boots Alliance will be holding an earnings conference call on Thursday, October 13th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "8277955".

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its earnings results on Thursday, January, 6th. The pharmacy operator reported $1.68 EPS for the quarter, topping analysts' consensus estimates of $1.35 by $0.33. The pharmacy operator had revenue of $33.90 billion for the quarter, compared to the consensus estimate of $32.87 billion. Walgreens Boots Alliance had a trailing twelve-month return on equity of 16.20% and a net margin of 4.00%. Walgreens Boots Alliance's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period last year, the firm earned $1.22 earnings per share.
Read the conference call transcript
.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Wednesday, July 13th. Investors of record on Friday, August 19th will be given a dividend of $0.48 per share on Friday, September 9th. This represents a $1.92 annualized dividend and a dividend yield of 5.84%. The ex-dividend date is Thursday, August 18th. This is an increase from the stock's previous quarterly dividend of $0.48.
Read our dividend analysis for WBA
.

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 5.92%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 30.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WBA will have a dividend payout ratio of 41.74% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WBA.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Fulton Bank N.A. (0.01%), Meyer Handelman Co. (0.01%), Moody National Bank Trust Division (0.00%), Lynch & Associates IN (0.00%), AdvisorNet Financial Inc (0.00%) and Somerset Trust Co (0.00%). Insiders that own company stock include Marco Patrick Anthony Pagni, Nancy M Schlichting and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $32.85.

How much money does Walgreens Boots Alliance make?

Walgreens Boots Alliance (NASDAQ:WBA) has a market capitalization of $28.39 billion and generates $132.51 billion in revenue each year. The pharmacy operator earns $2.54 billion in net income (profit) each year or $6.20 on an earnings per share basis.

How many employees does Walgreens Boots Alliance have?

The company employs 315,000 workers across the globe.

Does Walgreens Boots Alliance have any subsidiaries?
The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc..
Read More
How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The official website for the company is www.walgreensbootsalliance.com. The pharmacy operator can be reached via phone at (847) 315-3700, via email at investor.relations@wba.com, or via fax at 847-914-2804.

This page (NASDAQ:WBA) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.